Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, August 30, 2020, on "Face the Nation."
Watch CBS News
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, August 30, 2020, on "Face the Nation."
The new test — which cannot be done at home — uses the same technology used to test for the flu.
Some disinfecting products don't contain enough active ingredients to kill the coronavirus, regulators say.
Students at Florida State University have been arrested and charged with violating COVID-19 regulations by hosting an open house party, and Texas A&M is reporting an outbreak of more than 400 cases. Manuel Bojorquez has more details.
"I can assure the American people that this decision was made based upon sound science and data," Hahn told "CBS This Morning" co-host Gayle King.
AstraZeneca is starting Phase 1 trials of a potential antibody treatment for the coronavirus. Dr. Dyan Hes joins CBSN to discuss that, plus the FDA's controversial move to approve emergency use of convalescent plasma.
FDA Commissioner Dr. Stephen Hahn is defending his administration, saying politics did not play a role in the decision to grant emergency authorization of a possible coronavirus treatment. Only on "CBS This Morning," Hahn responds to charges of politicization of the FDA, and explains how the agency got the data to make the decison.
The FDA has authorized the emergency use of blood plasma for treatment of COVID-19. 70,000 patients in the U.S. have already received the therapy despite scientists warning the effectiveness is still not clear. Dr. Ron Elfenbein joins CBSN to discuss the move.
Several NIH officials last week warned the FDA commissioner against approving the use of convalescent plasma to treat the coronavirus.
Missed the second half of the show? The latest on James Comey's input on the Justice Department handling of the Russia investigation, colleges struggling with COVID-19 surges on campus, and Gottlieb defending the FDA from Trump allegations of political influence.
The Food and Drug Administration announced Sunday that it had authorized an emergency use declaration for convalescent plasma to treat the coronavirus, something President Trump touted as a "historic announcement." Watch his remarks here, along with Secretary of Health and Human Services Alex Azar and FDA commissioner Dr. Stephen Hahn.
The former FDA commissioner says he "firmly reject[s]" allegations that his former agency is slow-walking approvals for COVID treatments.
Mr. Trump claimed Saturday the FDA was slow-walking trials for coronavirus vaccines and therapeutics.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, August 23, 2020, on "Face the Nation."
The U.S. Food and Drug Administration is looking at a controversial procedure whereby a baby can be created from the DNA of three people. Dr. David Agus, professor of medicine at the University of Southern California, talks about the technique with the "CBS This Morning" co-hosts.
The FDA began two days of meetings about a controversial procedure that removes a mother's nucleus from her egg, leaving behind defective genes, and places it in a donor egg. The procedure aims to prevent children from inheriting diseases, but as Dr. Jon LaPook reports, critics have raised concerns.
Oregon Health & Science University's Dr. Shoukhrat Mitalipov is going before the FDA to seek approval for a new fertilization technique that would create babies from the DNA of three different parents. The controversial method would prevent the passing on of genetic diseases. KOIN's Lisa Balick reports.
Gottlieb said seroprevalence studies show roughly 8% of the U.S. population has been exposed to the coronavirus.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, August 16, 2020, on "Face the Nation."
Early last year, the FDA made a surprising announcement when it cut the recommended dose of the nation's most popular sleep drug, Ambien, by half - but only for women. Lesley Stahl reports on how much different men and women are, when it comes to medicine.
There’s more evidence of the growing diabetes epidemic and scientists try to pinpoint the best treatment for breast cancer patients. Alison Harmelin has the day’s top health stories.
Despite the fact that many other drugs are also metabolized differently by men and women, Ambien is the only drug on the market for which the FDA has different suggested doses based on sex. Lesley Stahl reports on Sunday, Feb. 9 at 7 p.m. ET/PT.
The Food and Drug Administration wants the food industry to get rid of artificial trans fats. Dr. Mark Hyman, medical director of The UltraWellness Center in Lenox, Mass., talks to the "CBS This Morning" co-hosts about the effects of the agency's decision.
The Food and Drug Administration says it plans to ban trans fats. Considered the unhealthiest fat by doctors, trans fats are commonly used as an additive to a variety of snacks from microwave popcorn to cookies and soups. Jeff Glor reports.
Federal regulators have flagged nearly 150 varieties to avoid because products may contain 1-propanol or methanol.